Emilio Justo, MD
Ophthalmology · Sun City, AZNPI 1407812647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Merz North America, Inc. at 40.3% of the total.
Across 56 payments — averaging $51.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$1K
- Alcon$411
- Glaukos Corporation$338
- Coopervision Inc.$305
- Carl Zeiss Meditec, Inc.$178
- Amgen$167
- plus $332 from 7 others
Across 4 payments — averaging $272.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$1K
What the payments were for
- Food & beverage$2,901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 15 | $1,169 |
| Alcon | 14 | $411 |
| Glaukos Corporation | 5 | $338 |
| Coopervision Inc. | 3 | $305 |
| Carl Zeiss Meditec, Inc. | 2 | $178 |
| Amgen(2 entities) | 3 | $167 |
| AbbVie(2 entities) | 6 | $111 |
| Dompe US, Inc. | 1 | $95 |
| Galderma Laboratories, L.p. | 3 | $59 |
| Omeros Corporation | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Bausch & Lomb Americas Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$935
- ASCLERA$300
- iStent Infinite$222
- PanOptix$133
- VisuMax$123
- ARTEVO 800$123
- MyDay Contact Lens$115
How this compares
$2,901 in reported general payments places this provider in the 65th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 344 | $3,534 |
| Prednisolone Acetate | 110 | $3,431 |
| ValacyclovirValacyclovir Hcl | 27 | $247 |
| Cephalexin | 25 | $138 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sun City
- Michael HorsleySun City$9K
- Warren HillMesa$1.1M
- Mark BarakatScottsdale$794K
- Anne ZakiSun City West$518K
- Pravin DugelPhoenix$176K
- Derek KunimotoMesa$138K
- Shamil PatelGlendale$116K
- Yuri McKeeMesa$100K
- Nishi ShahPhoenix$92K
- Lisa MihoraPeoria$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.